CN101291660A - 恢复正常呼吸节律的基于s-亚硝基硫醇的复方药品 - Google Patents

恢复正常呼吸节律的基于s-亚硝基硫醇的复方药品 Download PDF

Info

Publication number
CN101291660A
CN101291660A CNA200680038514XA CN200680038514A CN101291660A CN 101291660 A CN101291660 A CN 101291660A CN A200680038514X A CNA200680038514X A CN A200680038514XA CN 200680038514 A CN200680038514 A CN 200680038514A CN 101291660 A CN101291660 A CN 101291660A
Authority
CN
China
Prior art keywords
compound
therapeutic composition
respiratory
nitrosothiol
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200680038514XA
Other languages
English (en)
Chinese (zh)
Inventor
J·G·曼尼恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galleon Pharmaceuticals Inc
Original Assignee
Galleon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galleon Pharmaceuticals Inc filed Critical Galleon Pharmaceuticals Inc
Publication of CN101291660A publication Critical patent/CN101291660A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA200680038514XA 2005-09-20 2006-09-20 恢复正常呼吸节律的基于s-亚硝基硫醇的复方药品 Pending CN101291660A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71877205P 2005-09-20 2005-09-20
US60/718,772 2005-09-20

Publications (1)

Publication Number Publication Date
CN101291660A true CN101291660A (zh) 2008-10-22

Family

ID=37889538

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200680038514XA Pending CN101291660A (zh) 2005-09-20 2006-09-20 恢复正常呼吸节律的基于s-亚硝基硫醇的复方药品

Country Status (9)

Country Link
US (1) US20100035998A1 (enExample)
EP (1) EP1940369A4 (enExample)
JP (1) JP2009508965A (enExample)
KR (1) KR20080059229A (enExample)
CN (1) CN101291660A (enExample)
AU (1) AU2006292154A1 (enExample)
BR (1) BRPI0616144A2 (enExample)
CA (1) CA2623184A1 (enExample)
WO (1) WO2007035879A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7073501B2 (en) * 1999-02-04 2006-07-11 Univerity Technologies International Inc. Ventilatory stabilization technology
US20090025725A1 (en) * 2007-07-26 2009-01-29 Uti Limited Partnership Transient intervention for modifying the breathing of a patient
CN101888870B (zh) * 2007-10-26 2013-11-27 优特埃合伙有限公司 换气稳定系统
WO2009151744A1 (en) * 2008-04-02 2009-12-17 Galleon Pharmaceuticals, Inc. S-nitrosomercapto compounds and related derivatives
DE102010030096A1 (de) 2010-06-15 2011-12-15 Wacker Chemie Ag Silanvernetzende Zusammensetzungen
US20120101073A1 (en) * 2010-10-22 2012-04-26 Galleon Pharmaceutical, Inc. Novel Method For Treating Breathing Disorders or Diseases
WO2025207125A1 (en) * 2024-03-26 2025-10-02 The Regents Of The University Of California Combination pharmacological interventions for obstructive sleep apnea

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380758A (en) * 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
ZA963590B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
US20020183366A1 (en) * 2001-03-23 2002-12-05 Garvey David S. Cyclooxygenase-2 inhibitors, compositions and methods of use
CA2459647A1 (en) * 2001-08-20 2003-02-27 University Of Virginia Patent Foundation Use of s-nitrosothiol signaling to treat disordered control of breathing

Also Published As

Publication number Publication date
JP2009508965A (ja) 2009-03-05
EP1940369A4 (en) 2011-01-26
WO2007035879A2 (en) 2007-03-29
CA2623184A1 (en) 2007-03-29
EP1940369A2 (en) 2008-07-09
BRPI0616144A2 (pt) 2013-02-19
WO2007035879A3 (en) 2007-10-25
US20100035998A1 (en) 2010-02-11
AU2006292154A1 (en) 2007-03-29
KR20080059229A (ko) 2008-06-26

Similar Documents

Publication Publication Date Title
US11628186B2 (en) Method and composition for the reduction of viral replication, duration and spread of the COVID-19 and the flu
US20120101073A1 (en) Novel Method For Treating Breathing Disorders or Diseases
US20120270848A1 (en) Novel Compositions and Therapeutic Methods Using Same
US20120316189A1 (en) Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients diagnosed or undiagnosed respiratory illness
WO2012166909A1 (en) Compositions and methods for treating breathing control disorders or diseases
CN111670050A (zh) 用于治疗睡眠呼吸暂停的方法和组合物
AU2006291581A1 (en) Method and means of preventing and treating sleep disordered breathing
JP4896334B2 (ja) 睡眠時呼吸障害を治療及び診断する方法並びにその方法を実施する手段
US10682343B2 (en) Snoring treatment
US10881633B2 (en) Compositions and methods for stimulating ventilatory and/or respiratory drive
US20100105685A1 (en) S-Nitrosothiol Compounds and Related Derivatives
CN101291660A (zh) 恢复正常呼吸节律的基于s-亚硝基硫醇的复方药品
JPH0826997A (ja) バスピロン：睡眠誘起性無呼吸症剤
MX2008003935A (en) Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm
JP2021176903A (ja) イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの応用
US20250262181A1 (en) Compositions and methods for stimulating ventilatory and/or respiratory
JP6188784B2 (ja) 炎症性および免疫性疾患の治療のための組成物
JP2013511528A (ja) 喘息の急性憎悪の治療及びそれに罹患した患者の入院の可能性の低減
WO2005011591A2 (en) Method for the treatment of sleep disorders

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20081022